Scarica l'app Stockscreener
131.85
2.26%
-3.07
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$134.92
Aprire:
$134.475
Volume 24 ore:
419.78K
Relative Volume:
0.24
Capitalizzazione di mercato:
$20.13B
Reddito:
$4.28B
Utile/perdita netta:
$1.26B
Rapporto P/E:
16.70
EPS:
7.8957
Flusso di cassa netto:
$943.00M
1 W Prestazione:
-0.20%
1M Prestazione:
+9.28%
6M Prestazione:
+46.12%
1 anno Prestazione:
-8.68%
Intervallo 1D:
$131.09
$134.97
Intervallo di 1 settimana:
$131.09
$137.09
Portata 52W:
$68.70
$153.06
Illumina Inc Stock (ILMN) Company Profile
Nome
Illumina Inc
Settore
Industria
Telefono
(858) 202-4500
Indirizzo
5200 ILLUMINA WAY, SAN DIEGO, CA
Confronta ILMN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
131.74 | 20.62B | 4.28B | 1.26B | 943.00M | 7.8957 |
|
TMO
Thermo Fisher Scientific Inc
|
569.84 | 216.37B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
224.88 | 161.42B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
694.26 | 55.94B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
138.65 | 39.80B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
221.41 | 38.08B | 15.90B | 1.28B | 2.21B | 7.2842 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-12 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Reiterato | Citigroup | Neutral |
| 2025-02-28 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-02-10 | Downgrade | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-11-12 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-08-28 | Aggiornamento | Argus | Hold → Buy |
| 2024-08-16 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-01-04 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-11-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Iniziato | Bernstein | Underperform |
| 2023-07-05 | Ripresa | JP Morgan | Neutral |
| 2023-01-25 | Downgrade | Argus | Buy → Hold |
| 2023-01-05 | Iniziato | Scotiabank | Sector Perform |
| 2022-12-12 | Downgrade | Citigroup | Neutral → Sell |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-04 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Aggiornamento | Stifel | Hold → Buy |
| 2022-01-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Underweight |
| 2020-12-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-10-13 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Downgrade | Stifel | Buy → Hold |
| 2020-09-22 | Downgrade | UBS | Buy → Neutral |
| 2020-09-21 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-24 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-10-25 | Iniziato | Guggenheim | Buy |
Mostra tutto
Illumina Inc Borsa (ILMN) Ultime notizie
Gene Prediction Tool Industry Report 2025: Precision Genomics, - openPR.com
Illumina (NASDAQ:ILMN) Given New $130.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Twists, tangles, and transcription: Does epigenetics play a role in Alzheimer's? - Illumina
Thrivent Financial for Lutherans Purchases 684,802 Shares of Illumina, Inc. $ILMN - MarketBeat
United States DNA Sequencing Market 2031 | Growth Drivers, Key - openPR.com
Illumina, Inc. $ILMN Shares Bought by Neuberger Berman Group LLC - MarketBeat
Marex Group plc Makes New $1.24 Million Investment in Illumina, Inc. $ILMN - MarketBeat
NGS Based RNA Sequencing Market is growing at a CAGR of 19.7%, - openPR.com
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually - PR Newswire
Nikko Asset Management Americas Inc. Increases Stake in Illumina, Inc. $ILMN - MarketBeat
AQR Capital Management LLC Raises Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
4D Advisors LLC Purchases Shares of 30,000 Illumina, Inc. $ILMN - MarketBeat
Using genomic testing to deliver hope to families - Illumina
DNA Computing Market - GlobeNewswire Inc.
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Maple Rock Capital Partners Inc. Sells 26,145 Shares of Illumina, Inc. $ILMN - MarketBeat
Ilex Capital Partners UK LLP Raises Stock Position in Illumina, Inc. $ILMN - MarketBeat
Ieq Capital LLC Buys 176,611 Shares of Illumina, Inc. $ILMN - MarketBeat
Your lab’s new best friend for scalable proteomics: Illumina Protein Prep - Illumina
Illumina invests in MyOme to advance AI-driven genomic health models By Investing.com - Investing.com India
Illumina (NASDAQ: ILMN) invests in MyOme to launch AI-driven WGS trial in 2026 - Stock Titan
Illumina, Inc. $ILMN Shares Acquired by Natixis - MarketBeat
California Public Employees Retirement System Purchases 17,439 Shares of Illumina, Inc. $ILMN - MarketBeat
Stifel reiterates Buy rating on Illumina stock, cites multiple growth levers - Investing.com Australia
Leadership Perspectives: Illumina leads the industry in genomic AI - Illumina
Does Surging Genomics Consumables Demand Reshape The Bull Case For Illumina’s Recurring Revenue Engine (ILMN)? - Yahoo Finance
Invesco Ltd. Buys 444,543 Shares of Illumina, Inc. $ILMN - MarketBeat
Norges Bank Buys Shares of 239,640 Illumina, Inc. $ILMN - MarketBeat
Zacks.com featured highlights include Illumina, Commercial Metals and Newmont - Yahoo Finance
Precision oncology at your community’s doorstep - Illumina
First Trust Advisors LP Purchases 185,830 Shares of Illumina, Inc. $ILMN - MarketBeat
How Illumina’s (ILMN) Analyst Earnings Upgrade Will Impact Investors - Sahm
1832 Asset Management L.P. Makes New Investment in Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Shares Purchased by Arrowstreet Capital Limited Partnership - MarketBeat
Illumina Inc ILU Stock Analysis and ForecastAI-Driven Market Analysis & Free Lightning Fast Capital Gains - earlytimes.in
Illumina (ILMN): Assessing Valuation After a Quiet Share Price Rebound - Yahoo Finance
Illumina (NASDAQ:ILMN) Upgraded at Zacks Research - MarketBeat
Illumina at the 2025 China International Import Expo (CIIE) - Illumina
Will Illumina Inc. (ILU) stock draw ESG focused funds2025 Top Decliners & Smart Swing Trading Techniques - Newser
How Illumina Inc. (ILU) stock reacts to fiscal policiesPortfolio Risk Report & Weekly Chart Analysis and Trade Guides - Newser
AI in Biotech Market Is Booming Worldwide | NVIDIA, Illumina - openPR.com
Epigenetics Market size to reach $8.63 Billion by 2035 | Key - openPR.com
American Century Companies Inc. Sells 32,763 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina (ILMN) Moves to Strong Buy: Rationale Behind the Upgrade - Yahoo Finance
Schroder Investment Management Group Raises Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Will Illumina Inc. (ILU) stock keep high P E multiplesTrade Signal Summary & Safe Capital Allocation Plans - Newser
Can Illumina Inc. (ILU) stock sustain revenue momentumJuly 2025 Setups & Entry Point Confirmation Signals - Newser
Korea Investment CORP Reduces Position in Illumina, Inc. $ILMN - MarketBeat
Why Illumina Inc. (ILU) stock fits value portfoliosOil Prices & Fast Exit/Entry Strategy Plans - Newser
Genetic testing transformed her cancer care—and her family tree - Illumina
Illumina, Inc. $ILMN Stake Lifted by Spyglass Capital Management LLC - MarketBeat
Illumina Inc Azioni (ILMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.05%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):